Journal
MSYSTEMS
Volume 6, Issue 5, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/mSystems.01066-21
Keywords
vulvovaginitis; Candida; Lactobacillus; microbial interaction; biofilm; probiotics
Categories
Ask authors/readers for more resources
A recent study sheds light on the complex interactions between Candida and Lactobacillus in recurrent vulvovaginal candidiasis, suggesting that probiotic Lactobacillus-based therapies could be effective in combating these problematic fungal infections.
While extremely prevalent, painful, and difficult to treat, vulvovaginal candidiasis remains largely understudied in the field of women's health. In a recent issue of mSystems, McKloud et al. (E. McKloud, C. Delaney, L. Sherry, R. Kean, et al., mSystems 6:e00622-21, 2021, https://doi.org/10.1128/mSystems.00622-21) shed light on a pivotal role of a complex Candida-Lactobacillus interplay that may regulate the pathophysiology of recurrent vulvovaginal candidiasis (RVVC). This advancement not only gives new insight into the molecular mechanisms governing interkingdom interactions modulating RVVC disease, but also provides evidence that probiotic Lactobacillus-based therapeutic approaches could be efficient for fighting these problematical fungal infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available